Antihypertensive activity of 1-(2-(1,3-dimethyl-2-butenylidene)-hydrazino)-phthalazine (DJ-1461), a new phthalazine derivative.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure; D004305:Dose-Response Relationship, Drug; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006830:Hydralazine / Q000494:pharmacology / Q000627:therapeutic use; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics; D010793:Phthalazines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors
D000959:Antihypertensive Agents; D006571:Heterocyclic Compounds; D006834:Hydrazines; D010793:Phthalazines; D006830:Hydralazine